Mumbai-based specialty chemicals maker of THEIC, ethoxylates/propoxylates, antioxidants, HQEE and BC 700, serving PVC, coatings, agrochem, textile and personal-care industries.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 9 |
| Reserves | 4 | 19 | 46 | 59 | 75 | 88 | 100 | 243 |
| Borrowings | 109 | 88 | 79 | 77 | 85 | 100 | 88 | 0 |
| Other Liabilities | 26 | 24 | 41 | 34 | 61 | 108 | 84 | 53 |
| Total Liabilities | 147 | 138 | 173 | 177 | 229 | 304 | 279 | 305 |
| AssetsFixed Assets | 71 | 66 | 71 | 79 | 75 | 129 | 128 | 157 |
| CWIP | 0 | 1 | 7 | 1 | 45 | 35 | 37 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 76 | 71 | 95 | 97 | 109 | 141 | 115 | 142 |
| Total Assets | 147 | 138 | 173 | 177 | 229 | 304 | 279 | 305 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 15 | 19 | 35 | 33 | 14 | 42 | 48 | 10 |
| Cash from Investing | -2 | -7 | -4 | -17 | -9 | -40 | -50 | -20 |
| Cash from Financing | -30 | -24 | -7 | -9 | -11 | -11 | 2 | 34 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 12 | 13 | 32 | 17 | 6 | 1 | -2 | -11 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (46.5×) and current (38.0×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 31.4% growth and a 38× exit, ₹1214 only delivers your return if you pay ₹2,249. The price is currently baking in 18% growth.
EPS grows 31.4%/yr for 5 years, then fades to 6% over 2, exits at 38×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 31.4% | 41.97 |
| FY28 | 31.4% | 55.15 |
| FY29 | 31.4% | 72.46 |
| FY30 | 31.4% | 95.22 |
| FY31 | 31.4% | 125.12 |
| FY32 | 18.7% ·fade | 148.51 |
| FY33 | 6.0% ·fade | 157.42 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.